Structure Therapeutics Inc. is emerging in oral GLP-1 obesity drugs after Phase II success and rivals’ setbacks. Click here ...

Structure Therapeutics develops oral drugs for chronic diseases, with lead assets targeting diabetes, obesity, and cardiovascular care.

Capital structure refers to the mix of funding sources a company uses to finance its assets and its operations. The sources typically can be bucketed into equity and debt. Using internally generated ...

In today's rapidly evolving business landscape, the quest for sustainable growth is more critical than ever. As someone who has firsthand experience scaling a company sustainably, I have witnessed the ...

In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...

Some people say flat structures cause chaos in organizations. And while that can certainly be true, my experience has been different. After years of working for horizontal and vertical hierarchies, I ...